glp-1 ro side effects Agonists Explained: Definition, How They Work, Common GLP-1 Weight-loss Side Effects

European Medicines Agency Investigation On January 17, 2025, the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee launched a review of semaglutide medications such as Ozempic and Wegovy due to the increased risk of developing NAION

Receptor agonists are widely used in treating chronic diseases such as diabetes, asthma, neurological disorders, hormonal deficiencies, and cardiovascular conditions

Steps to maintain hygiene: Wash your hands thoroughly with soap before preparing the injection

Meanwhile, our Association will continue to work directly with our PEC members to help provide guidance